Supplementary Figure S1. Switchers: SALT trajectories from baseline to end of JAK1 and JAK2.

Published: 24 March 2026| Version 1 | DOI: 10.17632/xfygy2fvcj.1
Contributor:
yumi engelking

Description

Patient-level trajectories (gray lines) and group means (colored with 95% CIs) for switchers, stratified by reason for switching (insurance vs efficacy). Points represent baseline, end of 1stJAK inhibitor and end of 2nd JAK inhibitor; lower SALT indicates less hair loss.

Files

Categories

Salt, Alopecia Areata

Licence